Chimerix Inc. | Key People and Executives
M. Michelle Berrey
President, Chief Executive Officer & Director
Martha J. Demski
Chairman
Fred A. Middleton
Independent Director
Robert James Meyer
Independent Director
Edward F. Greissing
Independent Director
Ronald C. Renaud
Independent Director
Clarence Patrick Machado
Independent Director
Catherine Lynch Gilliss
Independent Director
James M. Daly
Independent Director
M. Michelle Berrey
President, Chief Executive Officer & Director
Timothy W. Trost
Chief Financial Officer, Secretary & Senior VP
Roy W. Ware
Chief Technology & Manufacturing Officer
Randall Lanier
Chief Science Officer
Joseph F. Rutledge
Chief Information Officer & VP-IT
William Garrett Nichols
Chief Medical Officer
Heather Knight-Trent
Vice President-Regulatory Affairs
Odin Naderer
VP-Clinical Pharmacology & Translational Medicine
Essy Mozaffari
Vice President-Market Access & Reimbursement
Kevin Reeves
Vice President-Sales & Marketing
Michelle LaSpaluto
Senior Director-Accounting
Joseph T. Schepers
Executive Director-IR & Corporate Communications
Michael A. Alrutz
Senior Vice President-General Counsel
Martha J. Demski
Chairman
Fred A. Middleton
Independent Director
Robert James Meyer
Independent Director
Edward F. Greissing
Independent Director
Ronald C. Renaud
Independent Director
Clarence Patrick Machado
Independent Director
Catherine Lynch Gilliss
Independent Director
James M. Daly
Independent Director
| Address |
2505 Meridian Parkway
Durham North Carolina 27713
United States
|
|
Employees
|
- |
| Website |
http://www.chimerix.com |
| Updated |
07/08/2019 |
| Chimerix, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes Brincidofovir for the treatment of adenovirus, cytomegalovirus, and smallpox. The company was founded by George R. |
